Examples of our recent work include:

  • Majesticare: Advised the shareholders of Midlands-based Majesticare on the sale of seven of the company’s care homes to Four Seasons Health Care, the UK’s largest independent health and social care provider.

  • Burrows & Close: Advised the shareholders on their disposal of the company to Boots UK, which has resulted in the sale of its 17 well-established pharmacies.

  • National Care Home Group: Advised on corporate, property and tax issues relating to sale of 13 care homes by the owners of a large national care home group.

  • PCCA: Advised in relation to its acquisition of The Specials Laboratory Holdings Limited, Craig & Hayward Limited and Arjun Products Limited (UK-based unlicensed medicines manufacturing and distribution companies).

  • Simbec Holdings Limited: Advised on its acquisition of the entire issued share capital of Orion Clinical Services Limited (and subsidiaries).

  • Advised various Finance Wales funds and Disruptive Capital Finance LLP (which manages the Sustainable Technology Fund) in relation to the sale of their shareholdings in Q Chip Limited to Midatech Pharma PLC and the simultaneous admission to AIM of Midatech Pharma PLC.

  • £50m Biotech Flotation: Clinigen is the first company of its kind to join the London Stock Exchange for around five years and Geldards' Life Science team advised majority shareholders, Andrew and Linda Leaver, throughout the process.

  • XenoGesis Limited: We have helped them implement a share option scheme and are in the process of revising their governing documents to ensure they are best placed to deal with their continued expansion.

  • Advising MapMyHealth on their start-up company providing the UK’s only type 2 diabetes self-management and collaborative care service, fully integrated with usual care. We continue to provide a broad range of advice to this business, including advising on investment into their company by their key employees and funders.

  • Life Sciences Hub: Founder member of the Life Sciences Hub in Cardiff Bay through our Scinapse Healthcare & Life Sciences product to provide fixed price professional services to early stage and growing companies in the sector.

  • Healthcare Manufacturer: Drafting, reviewing and negotiating a range of commercial agreements including a framework manufacture and supply agreement, a standard OEM manufacture and supply agreement, a standard non-disclosure agreement, distribution and agency agreements.

  • Global Corporate Group: Advising on a master supply agreement under which each member of the group could call off contracts for services from the supplier.

  • Cardiff University: Advising over the last 20 years or so on various healthcare related matters including material transfer agreements, clinical trials, patent licensing, research and collaboration agreements and drafting a standard framework agreement for clinical trials.

  • Cardiff University Spin-outs: Advising on patent licence agreements for a spin out company from the School of Biosciences of Cardiff University.

  • Developer & Manufacturer of Medical Diagnostics: Advising on material transfer agreements, patent licence agreements and supply agreements.

  • US Company: Advising in connection with the granting of exclusive agency and distribution rights to certain ophthalmic products in Europe.

  • Preparing standard form non-disclosure, framework supply, distribution and agency agreements for a client operating in the technical services field, providing training on how to use the standard form agreements to the client’s staff and then producing checklists for the staff to complete when using the standard form agreements.

  • Advising companies in the life science and healthcare sector on various framework supply agreements including agreements relating to the supply of reagents and on contracts for services including testing and evaluation services.

  • Advising on and drafting collaboration agreements for a range of HE and FE clients, many involving government or European funding.

  • Drafting a suite of standard form agreements for use by an FE institution together with guidance notes on the use of the same and the delivery of a training session on how to use the standard form agreements.

  • Advising a supplier of medical devices on a long term supply agreement.

  • Healthcare Brands International: Advising on a variety of matters including distribution agreements for their Erazaban and Sambucol product ranges and an agreement for conformity testing for packaging of products in their Sambucol range.

  • Leading Pharmaceutical Retailer & Manufacturer: Advising on the drafting of a range of supply and distribution agreements, product development agreements, licensing agreements and clinical trials agreements.

Share this page



Leading Welsh law firm completes head office move
Leading Welsh law firm Geldards LLP has completed the relocation of its head office to Cardiff’s flagship Capital Quarter development. Geldards will occupy more than 24,000 square feet of space at No.4 Capital Quarter on a ten-year lease.


Chairman's Blog - A Golf Instructor Saved My Life Tonight!
Chairman, David Williams, considers life as outcomes – those that we want and those that we don’t want.



Andrew Evans


Partner, Cardiff

+44 (0)29 2039 1761


Debra Martin


Partner, Derby

+44 (0)1332 378 355